Previous Page  25 / 26 Next Page
Information
Show Menu
Previous Page 25 / 26 Next Page
Page Background

Page 67

allied

academies

Archives of General Internal Medicine | Volume 2

&

April 04-05, 2018 | Miami, USA

International Conference on

Internal Medicine & Practice and Primary Care

International Meeting on

Breast Pathology & Cancer Diagnosis

Objectıve

: We used the results from the first three screening

rounds of BahcesehirMammography Screening Project (BMSP),

a 10-year (2009-2019) and the first organized population-based

screening program implemented in a county of Istanbul, Turkey,

to assess the potential cost effectiveness of a population based

mammography screening program in Turkey.

Materıals & Methods

: Two screening strategies were

compared: BMSP (includes three biennial screens for women

between 40-69) and Turkish National Breast Cancer Registry

Program (TNBCRP) which includes no organized population

based screening. Costs were estimated using direct data from

the BMSP project and the reimbursement rates of Turkish Social

Security Administration. The life years saved by BMSP were

estimated using the stage distribution observed with BMSP and

TNBCRP.

Results

: A total of 67 women (out of 7234 screened women)

were diagnosed with breast cancer in BMSP. The stage

distribution for AJCC stages O, I, II, III, IV was 19.4%, 50.8%,

20.9%, 7.5%, 1.5% and 4.9%, 26.6%, 44.9%, 20.8%, 2.8% with

BMSP and TNBCRP, respectively. The BMSP program is expected

to save 279.46 life years over TNBCRP with an additional cost of

$677.171, which implies an incremental cost-effectiveness ratio

(ICER) of $2.423 per saved life year. Since the ICER is smaller

than the Gross Demostic Product (GDP) per capita in Turkey

($10.515 in 2014), BMSP program is highly cost-effective and

remains cost-effective in the sensitivity analysis.

Conclusıon

: Mammography screening may change the stage

distribution of breast cancer in Turkey. Furthermore, an

organized population-based screening program may be cost

effective in Turkey and in other developing countries. More

research is needed to better estimate life years saved with

screening and further validate the findings of our study.

e:

vahitozmen@yahoo.com.tr

Cost-effectiveness of breast cancer screening in Turkey, a developing country: Results from Bahçeşehir

mammography screening project

Vahit Ozmen

Istanbul University, Turkey